|
Charlotte CFS/ME/FM Support Group Newsletter for June 8,
2009
Dear Readers,
The following article is so exciting to me. The first project Mrs.
Whittemore initiated was a groundbreaker and now she is planning something
much, much bigger. This is my first article in its entirety (written by
Cort Johnson via Co-Cure).
Also, see below the latest news from the CFIDS Association. Advocacy
projects for anyone who can and is interested in being involved in. You
can subscribe to get CFIDSLink E-Newsletters and get the news from the CAA
as soon as they publish it instead of when I am able to get a newsletter
out.
Nancy
by Cort (Johnson)on
June 7, 2009 (Author of Phoenix
Rising Web Site)
Annette and Harvey
Whittemore pulled off something of a miracle when they convinced the state
of Nevada to help them build the first chronic fatigue syndrome (ME/CFS)
research, treatment and eductation facility in the world.
The medical establishment,
after all, has been almost as hostile to ME/CFS patients as the disease
itself. The Whittemore-Peterson Neuro-immune Institute is an affront to
the medical community’s disregard for this disease - a beachhold of hope
that chronic fatigue syndrome (ME/CFS) patients can cheer about. But
Annette Whittemore has always had a large vision and she wants more - much
more.
What do armies do after
they establish a beachhead in hostile territory? They move on - and that’s
what Annette Whittemore proposes to do; if she has her way the WPI will be
just the beginning of a larger ‘invasion’ of the medical establishment.
Stand Up for M.E.
In the ‘Stand Up for M.E’. project she proposes that the federal
government build a network of five neuro-immune centers in the US that
revolve around a central hub at the WPI. The centers would cost $75
million dollars over five years. This is an audacious proposal indeed but
no more audacious than having the small state of Nevada build the first
chronic fatigue syndrome center in the world on it’s University campus.
It’s also very timely.
This is a unique period in the history of the NIH. With its 30% boost
from the Obama stimulus package (10 billion dollars) it’s simply awash in
money and it’s using most of it to build structures and buy equipment
i.e. to build just the kind of facilities that Annette proposes. This
opportunity will not come again.
It’s also a dangerous
time. The winners are going in lock in federal money for decades to come
which will, of course, leave less for everyone else. If we don’t get in
now it’s going to be all that much harder to get funds in the future.
Think of it - five WPI’s!
The federal budget on ME/CFS quadrupled. Real research centers. Real
treatment centers. The kind of research you want done finally being done -
in large quantities. The real possibility of a breakthrough. But
if it’s going to happen it’s going to happen now. The window of
opportunity is open now and but it’s closing.
Can Annette Whittemore
succeed on the federal level? In fact the WPI has already received
substantial federal help. No one should forget either that the Majority
leader of the Senate is Senator Harry Reid of Nevada, a strong chronic
fatigue syndrome (ME/CFS) supporter for many years. The entire Nevada
delegation is behind her.
What she needs now is us.
She particularly needs the help of people who are represented by
politicians sitting on the health committees. Please communicate with
your elected officials and ask them to support this project. Annette has
provided a sample letter below and please e-mail when you’ve done so.
Majority Members
Tom Harkin (D-IA), Chairman
Arlen Spector (D-PA),
Daniel Inouye (D-HI)
Herb Kohl (D-WI)
Patty Murray (D-WA)
Mary Landrieu (D-LA)
Richard “Dick” Durbin (D-IL)
Jack Reed (D-RI)
Mark Pryor (D-AR)
?
Minority Members
Thad Cochran (R-MA)
Judd Gregg (R-NH)
Kathryn Ann Bailey “Kay” Hutchinson (R-TX)
Richard Shelby (R-AL)
Lamar Alexander (R-TN)
SAMPLE LETTER
Re: The National Center for Neuro-Immune Disease Research with Regional
Medical Research Centers
Dear Senator/Congressman____________:
I am writing to urge you to support any congressional efforts to create a
new comprehensive center for the study of ME/CFS (Myalgic
Encephalomyelitis/ Chronic Fatigue Syndrome) and related neuro-immune
diseases in the State of Nevada and five regional medical research centers
across the United States. Up to four million people in America are
currently suffering from Chronic Fatigue Syndrome; millions more suffer
from similar diseases with no known cause. With the proposed partnership,
great progress and strides could be made in the research of these diseases
that have affected so many Americans for too long.
The new National Center for Neuro-Immune Disease Research would be
collaborative public/private partnership involving the University of
Nevada, Reno and the Whittemore-Peterson Institute for Neuro Immune
Diseases (WPI). The regional centers would serve as collaborative partners
of the national center sharing clinical research resources translating to
the most effective patient care in the shortest period of time.
The Whittemore Peterson Institute has already established a significant
research program in ME/CFS at the University of Nevada and will open in
the new Center for Molecular Medicine, a 100,000 sq ft. medical research
building, in the fall of 2010. The WPI research program is expanding its
reach into other neuroimmune diseases and the cancers that most often
develop in these patients. We are “shovel ready” for this important
leadership role and ask for your immediate support. We are requesting
funding levels of 12 million dollars a year for five years for the
National Research Center and 3 million per year for each additional
regional center or a total of 75 million dollars for the entire project.
If only 10 percent of the patients with ME/CFS were able to return to
work, the US would save over 1 billion dollars in lost wages and billions
more in health care costs.
Funds will be used to support various activities including, but not
limited to, seed grants, equipment, facilities, patient care, clinical
trials, education, public outreach, and the training of graduate students,
medical students, and residents. The new Institute and center will run
cooperative clinical diagnostic and treatment programs for patients with
neuroimmune diseases such as ME/CFS and fibromyalgia, facilitating
clinical trials of promising new diagnostic methods and treatments. It is
important that all patients with these neuroimmune diseases, throughout
the United States, have access to the highest quality of care.
A program of this nature would support the needs of a huge population of
patients who are truly underserved. Creating this partnership brings
important translational research to the forefront in this medical field.
Again, I urge you to support this effort and collaboration for neuro-immune
disease research and I sincerely thank you for all you’ve done for our
community and state.
Regards,
Annette Whittemore
Founder and President
Whittemore Peterson Institute
for Neuro Immune Disease
6600 N Wingfield Pkwy
Sparks, NV 89436
775-348-2335 Phone
775-348-2350 Fax
annette.whittemore@wpinstitute.org
Date: Mon, 1 Jun 2009 14:12:48 -0400
From: "The CFIDS Association of America
cfidslink@cfids.org via Co-Cure
Moderator" <ray@co-cure.org>
Subject:
Ask Secretary Sebelius to Take Action on the CFSAC Recommendations
Updated:
VIRTUAL LOBBY DAY ACTION #2
====================================
Write to Secretary of Health Sebelius
Take Action! Visit this page:
http://capwiz.com/cfids/utr/1/AEOFKOYXRK/JORWKOYYAC/3419517586]
Kathleen Sebelius is the Secretary of Health and Human Services. She
is responsible for all the agencies of the Department of Health & Human
Services (DHHS), including the National Institutes of Health (NIH) and
Centers for Disease Control & Prevention (CDC). On May 27-28, the federal
CFS Advisory Committee met and passed a set of three recommendations,
copied below. Please use our form letter to support swift implementation
of these recommendations by Secretary Sebelius.
Recommendations from the CFS Advisory Committee to the Secretary of Health
& Human Services
May 28, 2009
Recommendation #1: Establish progressive leadership at the CDC that can
achieve efficient meaningful progress in CFS research, clinical care and
education.
We have heard from the IACFS/ME president who represents the scientific
CFS community, call for new leadership within the CDC's CFS program. We
also learned that a CFS patient group has over 1000 signatures asking for
a change in leadership at the CDC's CFS program. Furthermore, we continue
to hear complaints from patients during public testimony about a number of
issues involving the leadership at the CDC. In addition, a number of
patient organizations have called for a change in leadership of the CDC's
CFS program. We are concerned with input from these diverse groups. We
also felt that the 5-year plan offered at our CFSAC meeting was ambiguous
concerning what could be accomplished with available resources, and also
seemed to lack a bold vision to significantly advance the field.
Approved by unanimous vote.
Recommendation #2: Provide adequate funding to effectively carry out a
detailed 5-year plan. This should include immediate progress in these
areas:
-
Identification of biomarkers and etiology of CFS
- Partnership with organizations representing CFS scientific expertise to
create guidelines for adult and pediatric management
- Provide web based guidelines for CFS management given our current state
of knowledge and expert opinion
- Provide comprehensive information about CFS in partnership with CFS
experts to the scientific community, medical and mental health
providers, educational institutions and the public for both adult and
pediatric CFS through DHHS resources
Approved by unanimous vote.
Recommendation #3: HHS establish 5 regional clinical care, research, and
education centers, centers which will provide care to this critically
underserved population, educate providers, outreach to the community, and
provide effective basic science, translational and clinical research on
CFS.
Approved by unanimous vote.
|
|
|
Grassroots Action Center Listserv |
|
 |
  |
| |
Updated/New Alerts Posted -- Please take action!
We've updated our
Virtual Lobby Day
Action
Alerts to reflect the recommendations made at last week's meeting
of the Chronic Fatigue Syndrome Advisory Committee (CFSAC). Check
out the Association's
Grassroots Action
Center
to take action on these five alerts:
-
Action 1:
Contact your local media to help raise awareness about
CFS.
-
Action 2:
Write to Secretary of Health Kathleen Sebelius and ask
her to act on the CFSAC's recommendations.
(Now updated to send your comments by e-mail.)
-
Action 3:
Ask President Obama, Vice President Biden and your elected
members of Congress to strengthen CFS research
-
Action 4:
Provide comments to the CDC on its 5-year research plan
for CFS. (Visit
http://www.cdc.gov/cfs/draft_5yr_research_plan.htm)
-
Action 5:
Thank Dr. Wanda Jones for making the CFSAC meeting
accessible by videocast. (Visit
http://videocast.nih.gov/Summary.asp?File=15130 to access
the archived video from Day 1.)
All of these Alerts can be found at
http://capwiz.com/cfids/home/. Since launching our fifth
annual Virtual Lobby Day on May 11, more than 3,000 messages have
been sent through the Grassroots Action Center to support
increased research, education and awareness. Even if you responded
to our mid-May alerts, add your voice now to these calls for
action!
More advocacy news will follow in the June edition of our free
monthly e-newsletter, CFIDSLink.
Click here to sign up for the monthly e-mailing. |
|
Ampligen for Chronic Fatigue Syndrome: Another Delay From the FDA
Tuesday May 26, 2009 from Adrienne Dellwo, About.com ME/CFS/FM Guide
NEWSBRIEF:
The FDA's May 25 deadline has passed, and once again we don't have a
decision on Ampligen (poly I: poly C12U), which is vying to become the
first approved treatment for
chronic fatigue syndrome.
According to Ampligen's manufacturer, Hemispherx Biopharma Inc., the FDA
says it will need another 1-2 weeks because of "staff scheduling changes."
In other
Ampligen-related news, Japanese researchers are now looking at whether
this drug is effective against
swine flu (H1N1).
·
More Ampligen Information:
http://chronicfatigue.about.com/b/2009/05/22/fdas-ampligen-decision-imminent.htm
·
http://chronicfatigue.about.com/b/2009/05/26/ampligen-for-chronic-fatigue-syndrome-another-delay-from-the-fda.htm
An Interesting Tidbit from Across the Pond
Editorship :
j.van.roijen@chello.nl
http://esme-eu.com/
<snip>
"Using new
biotechnological techniques, much of the underlying pathophysiology of the
disease has been unmasked. Several treatable clinical entities have been
discovered, but this information does not reach healthcare personnel. The
result is that patients remain undiagnosed and untreated for years with
something that might be fully treatable. This is a
huge drain on the economy, as the estimated socio-economic costs for
Europe are estimated to be 8020 billion annually."
The Basics about Fibromyalgia
http://www.fmnetnews.com/basics-symptoms.php
Biological, Psychological And Social Factors Influence Individual Pain
Differences
http://www.medicalnewstoday.com/articles/149294.php
Restless Leg
Syndrome
Subscribe to the
CFS and Fibro Newsletters - These are very good.
http://chronicfatigue.about.com/b/2009/05/18/fibromyalgia-restless-legs-syndrome-know-the-symptoms.htm
Date: Fri,
22 May 2009 12:04:52 -0400
From: Fred Springfield <fredspringfield1@verizon.net>
Subject: RES:
An investigation
into the cognitive deficits associated with chronic fatigue syndrome
An investigation into
the cognitive deficits associated with chronic fatigue syndrome.
Journal: Open Neurol J. 2009 Feb 27;3:13-23.
Authors: Thomas M, Smith A.
Affiliation: Centre for Occupational and Health Psychology, School of
Psychology, Cardiff University, UK.
NLM Citation: PMID: 19452031
This study addresses, among other things, the debate as to whether
cognitive deficits do occur with a diagnosis of Chronic Fatigue Syndrome (CFS).
Previous studies have indicated a potential mismatch between subjective
patient ratings of impairment and clinical assessment.
In an attempt to tackle some of the methodological problems faced by
previous research in this field, this study recruited a large sample of
CFS patients where adequate diagnosis had been made and administered an
extensive battery of measures. In doing so this study
was able to replicate previous published evidence of clear cognitive
impairment in this group and demonstrate also that these deficits occurred
independent of psychopathology.
The conclusion drawn is that cognitive impairments can be identified if
appropriate measures are used. Furthermore, the authors have shown that
performance changes in these measures have been used to assess both
efficacy of a treatment regime and rates of recovery.
[Note: This is an Open Access article, the fullcontent of which is
available for free at
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=19452031
]
Date: Fri, 22
May 2009 09:18:07 -0400
From: Lois Ventura <knothome@QCOL.NET>
Subject: NOT, MED: Dr. Byron Hyde's new book
See the top of this page for links (you may need to refresh your =
browser):
http://name-us.org/DefintionsPages/DefHyde.htm
Lois Ventura
Co-founder / Editor / Webmaster
National Alliance for Myalgic Encephalomyelitis
www.name-us.org
Fibromyalgia Network Newsletter
http://www.fmnetnews.com/pages/enews/May_09.html
Go here to
subscribe to the newsletter from the American Association for Pain
Management
Look on the left
side and go down until you find "newsletter."
http://www.aapainmanage.org/
|